Current Diabetes Reviews

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back Subscribe
Research Article

Trends in Total Antioxidant Status and Other Biochemical Parameters in Type 2 Diabetes Mellitus: A Case-control Study

Author(s): Remah Salih Al-Salman, Mohammad M. Al-Ahmad*orcid of author and Hiba Alameri

Volume 22, Issue 2, 2026

Published on: 09 January, 2025

Article ID: e15733998336940

Pages: 10

DOI: 10.2174/0115733998336940241219182916

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction/Objectives: Owing to the existing evidence of the implication of oxidative stress in the pathophysiology of type 2 diabetes mellitus (T2DM), the present study aims to investigate the correlation of serum total antioxidant status (TAS) with comorbidities, various biochemical parameters, and duration of T2DM. Various factors contributing to disease prevalence and trends in other biochemical parameters are assessed.

Methods: A retrospective observational study of 246 patients with T2DM whose data were retrieved from the Proficiency Health Diagnostic Lab System in Al Ain. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) program.

Results and Discussion: The prevalence of T2DM was found to be higher in gender (male), age (≥45 years), ethnicity (Middle Eastern), BMI (≥25), family history, and metabolic syndrome (hypertension and dyslipidemia). TAS was found to be significantly higher in patients with comorbidities, than in those without, particularly dyslipidemia and micro-albuminuria (p<0.05). TAS was weakly positively correlated with various T2DM biochemical parameters (p<0.05), except for Fasting blood glucose (FBG) (p=0.061). TAS was weakly negatively correlated with BMI (≥25) (p=0.042). Albumin-to-creatinine ratio (ACR) was statistically higher in hypertensives than normotensives (p=0.049). Duration of disease was only significantly correlated with ACR (r=0.325, p=0.001). Uric acid levels were statistically higher in patients with microalbuminuria than in patients without microalbuminuria (p=0.001).

Conclusion: TAS was higher in patients with dyslipidemia and microalbuminuria, suggesting the influence of other factors such as uric acid and lipid-lowering agents. TAS could be an important factor in the management of T2DM cases. This needs to be further investigated in future studies to fill the gap found in the literature.

Keywords: Type 2 diabetes, antioxidant status, micro-albuminuria, diabetic complications, oxidative stress, pathophysiology.

[1]
Gupta S, Sharma N, Arora S, Verma S. Diabetes: A review of its pathophysiology, and advanced methods of mitigation. Curr Med Res Opin 2024; 40(5): 773-80.
[http://dx.doi.org/10.1080/03007995.2024.2333440] [PMID: 38512073]
[2]
Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 2016; 387(10027): 1513-30.
[http://dx.doi.org/10.1016/S0140-6736(16)00618-8] [PMID: 27061677]
[3]
IDF Diabetes Atlas. (9th Ed..), Bagsværd, Denmark: International Diabetes Federation 2019.
[4]
Rahimlou M, Mirzaei K, Keshavarz SA, nezhad HA. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metab Syndr 2016; 10(1) (Suppl. 1): S60-5.
[http://dx.doi.org/10.1016/j.dsx.2015.09.015] [PMID: 26482964]
[5]
Bakhtiary M, Morvaridzadeh M, Agah S, et al. Effect of probiotic, prebiotic, and synbiotic supplementation on cardiometabolic and oxidative stress parameters in patients with chronic kidney disease: A systematic review and meta-analysis. Clin Ther 2021; 43(3): e71-96.
[http://dx.doi.org/10.1016/j.clinthera.2020.12.021] [PMID: 33526314]
[6]
Zhang ZY, Miao LF, Qian LL, et al. Molecular mechanisms of glucose fluctuations on diabetic complications. Front Endocrinol 2019; 10: 640.
[http://dx.doi.org/10.3389/fendo.2019.00640] [PMID: 31620092]
[7]
Shields HJ, Traa A, Raamsdonk VJM. Beneficial and detrimental effects of reactive oxygen species on lifespan: A comprehensive review of comparative and experimental studies. Front Cell Dev Biol 2021; 9: 628157.
[http://dx.doi.org/10.3389/fcell.2021.628157] [PMID: 33644065]
[8]
Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr 2019; 13(2): 1165-72.
[http://dx.doi.org/10.1016/j.dsx.2019.01.040] [PMID: 31336460]
[9]
Sharma A, Mittal S, Aggarwal R, Chauhan MK. Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment. Future J Pharm Sci 2020; 6(1): 130.
[http://dx.doi.org/10.1186/s43094-020-00151-w]
[10]
Alkadi H. A review on free radicals and antioxidants. Infect Disord Drug Targets 2020; 20(1): 16-26.
[http://dx.doi.org/10.2174/22123989OTEznMzIwTcVY] [PMID: 29952268]
[11]
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14(2): 88-98.
[http://dx.doi.org/10.1038/nrendo.2017.151] [PMID: 29219149]
[12]
Kuchelmeister F, van de Geer S. Finite sample rates for logistic regression with small noise or few samples. arXiv:230515991 2024; 1-6.
[http://dx.doi.org/10.1007/s13171-024-00358-6]
[13]
Rodgers JL, Jones J, Bolleddu SI, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis 2019; 6(2): 19.
[http://dx.doi.org/10.3390/jcdd6020019] [PMID: 31035613]
[14]
Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 2020; 63(3): 453-61.
[http://dx.doi.org/10.1007/s00125-019-05040-3] [PMID: 31754750]
[15]
Awadi AF, Hassanein M, Hussain HY, et al. Prevalence of diabetes and associated health risk factors among adults in dubai, united arab emirates: Results from dubai household survey 2019. DOAJ 2021; 26(4): 164-73.
[16]
Sulaiman N, Mahmoud I, Hussein A, et al. Diabetes risk score in the united arab emirates: A screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2018; 6(1): e000489.
[http://dx.doi.org/10.1136/bmjdrc-2017-000489] [PMID: 29629178]
[17]
Nordström A, Hadrévi J, Olsson T, Franks PW, Nordström P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J Clin Endocrinol Metab 2016; 101(10): 3740-6.
[http://dx.doi.org/10.1210/jc.2016-1915] [PMID: 27490920]
[18]
Aamir AH, Haq UZ, Mahar SA, et al. Diabetes prevalence survey of Pakistan (dps-pak): Prevalence of type 2 diabetes mellitus and prediabetes using hba1c: A population-based survey from pakistan. BMJ Open 2019; 9(2): e025300.
[http://dx.doi.org/10.1136/bmjopen-2018-025300] [PMID: 30796126]
[19]
Gatineau M, Hancock C, Holman N, et al. Adult obesity and type 2 diabetes. England: Public Health 2014; pp. 5-14.
[20]
Center, Dubai Statistics. Number of population estimated by nationality-emirate of dubai. 2017. Available from: https://www.dsc.gov.ae/Report/DSC_SYB_2017_01%20_%2003.pdf
[21]
Hamoudi R, Saheb Sharif-Askari N, Saheb Sharif-Askari F, et al. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep 2019; 9(1): 17437.
[http://dx.doi.org/10.1038/s41598-019-53505-7] [PMID: 31767874]
[22]
Asiimwe D, Mauti GO, Kiconco R. Prevalence and risk factors associated with type 2 diabetes in elderly patients aged 45-80 years at Kanungu District. J Diabetes Res 2020; 2020(1): 1-5.
[http://dx.doi.org/10.1155/2020/5152146]
[23]
Kumar KN, Katkuri S, Ramyacharitha I. A study to assess prevalence of diabetes mellitus and its associated risk factors among adult residents of rural Khammam. IJCMPH 2018; 5(4): 1360-5.
[24]
Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: Second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ Open 2018; 8(8): e020961.
[http://dx.doi.org/10.1136/bmjopen-2017-020961] [PMID: 30082350]
[25]
Thakur SK, Dhakal SP, Parajuli S, Sah AK, Nepal SP, Paudel BD. Microalbuminuria and its risk factors in type 2 diabetic patients. J Nepal Health Res Counc 2019; 17(1): 61-5.
[http://dx.doi.org/10.33314/jnhrc.v17i01.1620] [PMID: 31110390]
[26]
Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 2015; 6(3): 456-80.
[http://dx.doi.org/10.4239/wjd.v6.i3.456] [PMID: 25897356]
[27]
Griendling KK, Camargo LL, Rios FJ, Lopes AR, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res 2021; 128(7): 993-1020.
[http://dx.doi.org/10.1161/CIRCRESAHA.121.318063] [PMID: 33793335]
[28]
Cruz GM, Vera MI, Cañetas CTE, et al. Chaya leaf decreased triglycerides and improved oxidative stress in subjects with dyslipidemia. Front Nutr 2021; 8: 666243.
[http://dx.doi.org/10.3389/fnut.2021.666243] [PMID: 34368206]
[29]
Rajeshwari A, Divija DA, Somshekhar GN. Study of serum sialic acid, microalbuminuria, oxidative stress and antioxidant status in diabetic nephropathy. IJBB 2019; 15(1): 17-25.
[30]
Aslan M, Sabuncu T, Kocyigit A, Celik H, Selek S. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2007; 17(10): 734-40.
[http://dx.doi.org/10.1016/j.numecd.2006.08.005] [PMID: 17321120]
[31]
Kharroubi AT, Darwish HM, Akkawi MA, et al. Total antioxidant status in type 2 diabetic patients in palestine. J Diabetes Res 2015; 2015: 1-7.
[http://dx.doi.org/10.1155/2015/461271] [PMID: 26090472]
[32]
Najafi A, Pourfarzam M, Zadhoush F. Oxidant/antioxidant status in type-2 diabetes mellitus patients with metabolic syndrome. J Res Med Sci 2021; 26(1): 6.
[http://dx.doi.org/10.4103/jrms.JRMS_249_20] [PMID: 34084185]
[33]
Lim S, Barter P. Antioxidant effects of statins in the management of cardiometabolic disorders. J Atheroscler Thromb 2014; 21(10): 997-1010.
[http://dx.doi.org/10.5551/jat.24398] [PMID: 25132378]
[34]
German CA, Liao JK. Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol 2023; 97(6): 1529-45.
[http://dx.doi.org/10.1007/s00204-023-03492-6] [PMID: 37084080]
[35]
Kurajoh M, Fukumoto S, Yoshida S, et al. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry. Sci Rep 2021; 11(1): 7378.
[http://dx.doi.org/10.1038/s41598-021-86962-0] [PMID: 33795813]
[36]
Indriani V, Lestari T, Dewantari V. Duration of diabetes as an important risk factor of microalbuminuria in type 2 diabetes. Universa Medicina 2020; 39(1): 42-6.
[http://dx.doi.org/10.18051/UnivMed.2020.v39.42-46]
[37]
Saleem T, Dahpy M, Ezzat G, Abdelrahman G, Aziz AE, Farghaly R. The profile of plasma free amino acids in type 2 diabetes mellitus with insulin resistance: Association with microalbuminuria and macroalbuminuria. Appl Biochem Biotechnol 2019; 188(3): 854-67.
[http://dx.doi.org/10.1007/s12010-019-02956-9] [PMID: 30706418]
[38]
Ogunmuyiwa O. Hypertension and diabetes comorbidity: Factors that are associated with their joint occurrence. Georgia State University: Doctoral dissertation, Thesis 2023.
[39]
Nicola P, Ardeleanu E, Gadau C, et al. Evaluation of biochemical and clinical parametres of hypertension with type 2 diabetes mellitus. Revista de Chimie 2018; 69(9): 2402-6.
[http://dx.doi.org/10.37358/RC.18.9.6542]
[40]
Khan ZK, Majeed A, Rashid A. The risk factors associated with diabetic dyslipidemia and anthropometric parameters linked with and without dyslipidemia in type 2 diabetes mellitus. PAFMJ 2020; 70(2): 628-33.